Trials

A phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic gemcitabine and capecitabine in combination with cetuximab in patient with non-resectable liver metastases from cholangiocarcinoma

Cancer type: Cholangiocarcinoma

Phase: II

Principal Investigator: Larsen Ole

Country: DK

Keywords: Denmark, Herlev, Intra-hepatic chemotherapy in patient with non-resectable liver metastases from cholangiocarcinoma

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01247337?term=NCT01247337&rank=1